Dysregulation of ADAR activity or RNA editing has been associated with various diseases, including cancer, neurological disorders (such as epilepsy and amyotrophic lateral sclerosis), and autoimmune diseases, suggesting that ADARs may be recognized as potential therapeutic targets. The gene discussed is ADAR; the disease is cancer.